1-3 of 3
Claudette Bethune, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pharmacokinetics and Pharmacodynamics of Ionis-FXI Rx , an Antisense Inhibitor of Factor XI, in Patients with End-Stage Renal Disease on Hemodialysis

Claudette Bethune, PhD, Michael Walsh, MD, PhD, Bill Jung, PhD, Rosie Yu, PhD, Richard S Geary, PhD, Sanjay Bhanot, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1116.
https://doi.org/10.1182/blood.V130.Suppl_1.1116.1116
Published: 2017
Journal Articles

Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis

Harry Roger Buller, MD PhD, Claudette Bethune, PhD, Sanjay Bhanot, MDPhD, David Gailani, MD, Brett P. Monia, PhD, Gary E. Raskob, PhD, Annelise Segers, Peter Verhamme, MD PhD, Jeffrey I. Weitz, MDFRCPC
Journal: Blood
Blood (2014) 124 (21): LBA-1.
https://doi.org/10.1182/blood.V124.21.LBA-1.LBA-1
Published: 2014
Journal Articles

ISIS-FXI Rx , A Novel and Specific Antisense Inhibitor of Factor XI, Caused Significant Reduction in FXI Antigen and Activity and Increased aPTT without Causing Bleeding in Healthy Volunteers

Que Liu, MD PhD, Claudette Bethune, PhD, Esmat Dessouki, MD, John Grundy, PhD, Brett P. Monia, PhD, Sanjay Bhanot, MD PhD
Journal: Blood
Blood (2011) 118 (21): 209.
https://doi.org/10.1182/blood.V118.21.209.209
Published: 2011